Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
Mohammad Mehdi Khaleghi1, Faezeh Rouhi2, Kourosh Eslami3
1Department of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Abstract:
Breast cancer is considered one of the most abundant malignancies with high morbidity and mortality. Traditional cancer treatments possess various weaknesses, including a lack of specificity and numerous side effects. Novel cancer therapies aim to overcome the shortcomings of traditional therapies and offer more efficient and safe treatments. Designing and identifying novel proteins that can practically and specifically inhibit tumors by inducing apoptosis can interest researchers in this field. This review discusses recent studies on the use of four promising proteins, KAI1, Apoptin, BIF-1, and DFF-40, for breast cancer treatment. This study also focuses on alterations in the expression of the androgenic proteins and novel strategies for better penetration and delivery of these proteins. Lastly, prospects for protein-based targeted cancer therapy and future studies in this field are highlighted.
Insights
This review explores novel protein therapies, including KAI1, Apoptin, BIF-1, and DFF-40, for breast cancer treatment, focusing on targeted apoptosis induction and improved delivery strategies for enhanced efficacy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Breast cancer presents significant global health challenges with high morbidity and mortality.
- Traditional treatments often lack specificity and cause severe side effects.
- There is a critical need for innovative, targeted therapies with improved safety and efficacy.
Purpose of the Study:
- To review recent advancements in protein-based targeted therapy for breast cancer.
- To evaluate the therapeutic potential of KAI1, Apoptin, BIF-1, and DFF-40 proteins.
- To discuss strategies for enhancing protein delivery and overcoming treatment resistance.
Main Methods:
- Literature review of recent studies on specific proteins and breast cancer.
- Analysis of protein expression alterations, particularly androgenic proteins.
- Exploration of novel drug delivery systems for protein therapeutics.
Main Results:
- Identified KAI1, Apoptin, BIF-1, and DFF-40 as promising agents for inducing apoptosis in breast cancer cells.
- Highlighted the importance of understanding androgenic protein expression in treatment response.
- Discussed innovative strategies for improved protein penetration and targeted delivery.
Conclusions:
- Protein-based targeted therapy offers a promising avenue for more effective and safer breast cancer treatment.
- Further research into protein delivery and expression modulation is crucial for clinical translation.
- These novel proteins represent a significant advancement in the pursuit of personalized breast cancer therapies.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy


